The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
Loss of cell cycle control is characteristic of tumorigenesis. The protein p21 is the founding member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein. p21 is transcriptionally controlled by p53 and p53-independent pathways. Its expression is increased in response to various intra- and extracellular stimuli to arrest the cell cycle ensuring genomic stability. Apart from its roles in cell cycle regulation including mitosis, p21 is involved in differentiation, cell migration, cytoskeletal dynamics, apoptosis, transcription, DNA repair, reprogramming of induced pluripotent stem cells, autophagy and the onset of senescence. p21 acts either as a tumor suppressor or as an oncogene depending largely on the cellular context, its subcellular localization and posttranslational modifications. In the present review, we briefly mention the general functions of p21 and summarize its roles in differentiation, migration and invasion in detail. Finally, regarding its dual role as tumor suppressor and oncogene, we highlight the potential, difficulties and risks of using p21 as a biomarker as well as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–213 of 213
The Cyclin-Dependent Kinase Inhibitor Butyrolactone Is a Potent Inhibitor of p21WAF1/CIP1Expression
Sax, J. K., Dash, B. C., Hong, R., Dicker, D. T., & El‐Deiry, W. S. (2002) · Cell Cycle · doi:10.4161/cc.1.1.105 · Cited by 25
Overcoming of Radioresistance in Human Gliomas by p21WAF1/CIP1 Antisense Oligonucleotide
Kokunai, T., Urui, S., Tomita, H., & Tamaki, N. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010645205169 · Cited by 23
Cytoplasmic p21WAF1/CIP1 expression in human hepatocellular carcinomas
Shiraki, K., & Wagayama, H. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01320.x · Cited by 23
Takeshima, Y., Yamasaki, M., Nishisaka, T., Kitaguchi, S., & Inai, K. (1998) · Carcinogenesis · doi:10.1093/carcin/19.10.1755 · Cited by 22
Seong, H., & Ha, H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1616-z · Cited by 20
The role of p53 in limiting somatic cell reprogramming
Liu, Y., Hoya-Arias, R., & Nimer, S. D. (2009) · Cell Research · doi:10.1038/cr.2009.121 · Cited by 19
p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells
Ghanem, L. R., & Steinman, R. A. (2006) · Leukemia Research · doi:10.1016/j.leukres.2005.12.023 · Cited by 14
The role of p53 in limiting somatic cell reprogramming
Yan, Liu, Ruben, Hoya-Arias, Stephen, & Nimer (2009) · Cited by 11
Inducer and inhibitor: “Antagonistic duality” of p21 in differentiation
Gartel, A. L. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.02.025 · Cited by 8
Evangelou, K., Galanos, P., & Gorgoulis, V. G. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1215776 · Cited by 8
Ping, B., He, X., Xia, W., Lee, D.-F., Wei, Y., Yu, D., Mills, G., Shi, D., & Hung, M.-C. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.5.1103 · Cited by 7
Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma
Zaidi, A. R. S., Dresman, S., Burt, C., Rule, S. A., & McCallum, L. M. R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0494-y · Cited by 6
(1995) · PubMed
Cited by
Role of p53 in the Regulation of Cellular Senescence
Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A. (2020) · Biomolecules · doi:10.3390/biom10030420 · Cited by 639
“The p53/p21cip1 axis in the context of cellular senescence has been implicated in several cancer types, including breast cancer, cholangiocarcinoma, head and neck squamous cell cancer, liver cancer, lung cancer, colorectal cancer, as well as ovarian cancer [102].”
BackgroundResearch progress on interferon and cellular senescence
Wang, D., Chen, K., Wang, Z., Wu, H., & Li, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202400808rr · Cited by 23
Metadata
- Authors
- Kreis, N.-N., Louwen, F., & Yuan, J.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-08-21
- Volume
- 11
- Issue
- 9
- Pages
- 1220
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2969845879
- Cited by
- 298
- References
- 213
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.